Eliot Engel actually said...

"I am very troubled by the redesign. I am worried that the redesign will be used as an excuse to cut back."

"I was happy to work with Congresswoman McMorris Rodgers to include provisions on biomarker development qualification."

"I feel that there should be formalized, straightforward ways to gauge the safety and efficacy of medical treatments."

"I have long been a committed advocate for those suffering from rare diseases in their families."